The growing popularity of GLP-1-based medications has transformed the conversation around weight loss.
Originally developed for the management of type 2 diabetes and obesity, these glucagon-like peptide 1 drugs have gained widespread attention due to their effectiveness in helping suitable patients achieve significant weight reduction.
Already a subscriber? Log in
Get 20% OFF The Star Digital Access
Cancel anytime. Ad-free. Unlimited access with perks.
